Podcast: Efforts Toward Earlier Diagnosis
Delayed or wrong Parkinson's diagnosis impacts individuals' treatment and research toward new therapies. Investigators are working to validate biological measures of disease that could help confirm diagnosis and identify Parkinson's earlier in the disease process.
"Biomarkers are tools to understand not only who has Parkinson's and who doesn't but also to track the symptoms of Parkinson's as they progress and to understand whether a particular drug treatment is working or not," says Samantha Hutten, PhD, MJFF senior associate director of research programs, in our latest podcast.
Join our webinar this Thursday, March 17 at 12 p.m. ET/9 a.m. PT to hear more from Dr. Hutten and other panelists on the search for a Parkinson's diagnostic tool.
Watch archived webinars on topics from exercise and complementary medicine to stem cells and sexual dysfunction.
Ander nieuws
[Comment] A new step towards targeting tau
Progressive supranuclear palsy is a rare neurodegenerative disease characterised by an axial parkins...
[Review] CSF and blood biomarkers for Parkinson’s disease
In the management of Parkinson's disease, reliable diagnostic and prognostic biomarkers are urg...
Parkinson’s disease patient: ‘I can walk… it’s really helped me’
Parkinson's disease patient Gail Jardine can walk more freely after having a spinal implant fit...